Home › Chronic Pain › NCT06038409

Ketamine Treatment Plans for Chronic Conditions

Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

Must have an identifiable chronic condition.

Exclusion Criteria:

Healthy population

About the study

A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.

What is being tested

• Ketamine (drug)

Sponsor: RIVER Foundation · Participants: 500 · Started: Jan 1, 2023

Contact the study team

• Ed Lesofski · Phone: 406-465-9504
• James Taggart, MD · Phone: 415-713-6654

Official record on ClinicalTrials.gov — NCT06038409

Locations in the U.S.

Conditions

• Chronic Pain
• Depression
• Anxiety

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.